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Abstract
The Golden Crescent region of South Asia—comprising Afghanistan, Iran, and Pakistan—is a principal global site for
opium production and distribution. Over the past few decades, war, terrorism, and a shifting political landscape
have facilitated an active heroin trade throughout the region. Protracted conflict has exacerbated already dire
socio-economic conditions and political strife within the region and contributed to a consequent rise in opiate
trafficking and addiction among the region’s inhabitants. The worsening epidemic of injection drug use has paralleled
the rising incidence of HIV and other blood-borne infections in the region and drawn attention to the
broader implications of the growing opiate trade in the Golden Crescent. The first step in addressing drug
use is to recognize that it is not a character flaw but a form of mental illness, hence warranting humane
treatment of drug users. It is also recommended that the governments of the Golden Crescent countries
encourage substitution of opium with licit crops and raise awareness among the general public about the
perils of opium use.
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Background
The Golden Crescent of South Asia comprises Afghanistan,
Iran, and Pakistan [1, 2]. This region is considered a global
hub for heroin and related opiate production and trafficking
[3, 4]. In recent years, these countries have battled many
challenges, including political turmoil, economic instability,
war, and terrorism. The current review explores how such
forces may have influenced the growth and expansion of
the heroin trade within the region and how the trade has
had implications for an epidemic of injection drug use, ris-
ing incidence of human immunodeficiency virus (HIV) and
other blood-borne infections [5].
There are three well-defined heroin trafficking routes
that originate from the Golden Crescent region. The
Balkan route operates through Iran and Turkey and traf-
fics the bulk of Afghan heroin to Europe. The Northern
route supplies heroin to the Russian Federation and
Central Asia. Due to increased law enforcement along
these two routes, alternate routes have emerged, collect-
ively called the Southern route, that traffics heroin to
Iran and Pakistan, and from these countries, via sea and
air, to other parts of the world (Fig. 1) [6, 7].
Heroin is a derivative of opium that is obtained from
the poppy plant, Papaver somniferum [8]. People
addicted to heroin experience intense craving for the
drug that interferes with their abilities to manage work,
family, and other life commitments [9]. Long-term her-
oin use is thought to accelerate aging processes and is
associated with liver and heart disease [10, 11]. Injecting
heroin, through the sharing of contaminated needles, is
also a major risk factor for blood-borne infections, such
as HIV, hepatitis B virus (HBV), and hepatitis C virus
(HCV). In a study of 483 people who inject drugs
(PWID) recruited over a 2-year period from 2007 to
2009, Todd et al. found that those who had ever shared
needles or syringes had higher odds of contracting HIV
and/or HCV [5]. It is a common practice for PWID
to—as a sign of brotherhood—share the same drug/
blood-charged needle among themselves. A study con-
ducted in Quetta and Lahore, Pakistan, found that ap-
proximately 92% of PWID practiced “jerking” where
blood is drawn into the syringe and the drug/blood mix-
ture is re-injected—a practice also referred to as “boot-
ing” or “registering” [12]. Some PWID also deliberately
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inject themselves with another’s blood in an effort to
share the high or assuage the withdrawal symptoms—a
practice referred to as “flashblood” or in Afghanistan,
khoon bozee [5, 12].
Asia is home to two thirds of the world’s opiate users.
At the end of 2006, the number of heroin users in
Afghanistan, Iran, and Pakistan tallied 50,000 [13],
200,000 [14], and 484,000 [15], respectively. In 2009,
these figures had risen to 120,000 [13], 391,000 [16], and
547,000 [16], respectively. Since the early 1990s, an HIV
epidemic has been flourishing among PWID in Pakistan,
where in 2011, one third of PWID were infected with
HIV [17]. In Iran, a 2010 survey estimated the HIV
prevalence among PWID to be 15% [18]. High preva-
lence of HIV, HBV, and HCV has also been reported
among Afghan refugees [19]. In this article, we trace the
heroin trade in the Golden Crescent region and postu-
late how it may have contributed to a rise in HIV and
other blood-borne infection incidence, particularly
among high-risk populations.
Opium trade in Afghanistan
On Christmas Eve 1979, the army of the Soviet Union
invaded Afghanistan. Over the course of the war’s
9 years, many madrassas (religious seminaries) material-
ized in Afghanistan [20] and Pakistan [21]. Many of the
graduates of these madrassas formed the core of the
Taliban movement that started besieging Afghanistan in
1993–1994 until the war with the USA in 2001 [22, 23].
The decade-long war with the Soviet Union had resulted
in the destruction of the nation’s subsistence agriculture
[24]. This, coupled with taxes paid to regional warlords,
left farmers with little choice but to plant opium, a crop
that requires little water and returns high profits. The
profits obtained from the sale of opium were used to
fund, among other things, the Afghan resistance to
Soviet occupation. Opium production rose steadily
throughout the 1980s and 1990s until 2000 when opium
production fell precipitously on account of a fatwa is-
sued by Taliban leader Mullah Omar that banned poppy
cultivation [25, 26]. Opium production resumed after
the fall of the Taliban in 2001 (Figs. 2a and 3). The
opium trade, though not reliable, has been a relatively
lucrative enterprise for Afghan farmers. Between 2002
and 2008, poppy farmers made $6.4 billion. The drug
traffickers, on the other hand, earned $18 billion [7].
Much of the profits fell into the hands of warlords and
Taliban militias, funding terrorist activities. As the
opium trade funded terrorism in Afghanistan, it also
weakened the integrity of civic institutions, further facili-
tating the illicit opium trade [27].
A 2010 study describes the following heroin use pat-
terns in Afghanistan, based on patient profile: the war
pattern, the refugees’ pattern, and the social and eco-
nomic crisis pattern. The war pattern entails long-term
drug use (>30 years) by ex-Afghan soldiers. The refu-
gees’ pattern includes people who began to use drugs
while they were refugees in Pakistan and Iran. The social
Fig. 1 The Golden Crescent. The three Golden Crescent countries are indicated. Pink, yellow, and blue arrows indicate respectively the Northern,
Balkan, and Southern routes of heroin trafficking [7, 104, 105]
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and economic crisis pattern includes people who began to
use drugs as a means of escape from their harsh realities
[28]. The North Atlantic Treaty Organization (NATO) in
2008 declared that along with the war on terrorism, the
war on drugs is also a prerogative of the international
community and NATO troops can be employed to help
with anti-narcotics operations [28].
Injection drugs and HIV in Afghanistan
Three decades of conflict in Afghanistan have given rise
to a shattered economy and disintegrated society. All
available indicators suggest a rise in the incidence of de-
pression and other mental illnesses [29]. Residents of a
deprived nation looking for means of escape have in-
creasingly turned to heroin, which has been cheap and
plentiful in the country [30]. According to United
Nations Office on Drugs and Crime (UNODC) estimates,
23,000 individuals injected drugs in Afghanistan in 2009,
up from 19,000 in 2005. The Integrated Bio-Behavioral
Fig. 2 Timeline showing major events in the history of a Afghanistan [25, 26, 73, 106, 107], b Pakistan [54, 55], and c Iran [66, 67, 69, 70, 108] that
directly affected the politics of the poppy in these countries
Fig. 3 Opium production (metric tons) in Afghanistan from 1980 to
2014 [73, 106]
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Survey (IBBS) conducted in Afghanistan in the same year
showed that 27% of those who injected drugs also shared
needles [31]. In 2012, the IBBS estimated the prevalence
of HIV in those who inject drugs to be 4.4% [32, 33].
There is a real risk that HIV will spread from PWID
to other high-risk populations with increasing frequency
[30]. According to the IBBS 2012, the percentage of fe-
male sex workers (FSWs) living with HIV in Afghanistan
was 0.3%. In 2009, there were more than 18,000 pris-
oners in Afghanistan, predicted to rise to 30,000 by 2015
[31]. Prisoners are considered to be at risk of contracting
blood-borne infections because they are more likely to
share needles, as they are scarce in prisons. Additionally,
injection drug use is popular among prisoners, since
injecting of drugs can be performed more surreptitiously
than smoking. A study reports that those who inject in
prison are five times more likely to be infected with HIV
than those who do not. Prisoners may also face sexual
abuse by prison guards or other prisoners, and this puts
them at further risk for contracting HIV and other sexu-
ally transmitted infections (STIs) [34]. Lastly, men who
have sex with men (MSM) are an underreported high-
risk population in Afghanistan. The IBBS 2012 estimates
the prevalence of HIV in MSMs to be 0.5%. From this
same survey, it was found that two thirds of the MSMs
in Kabul had unprotected anal intercourse in the previ-
ous year [31]. The most recent estimates place the
prevalence of HIV in the general Afghan population at
<0.1% [35]. In spite of the low prevalence, the rising inci-
dence of HIV and other STIs among PWID, FSWs,
MSMs, and prisoners [31, 36, 37] raise concerns that
these infections might bridge into general populations.
Afghan refugees in Iran and Pakistan
Afghan refugees constitute one of the biggest displaced
populations in the world [38]. Following the 1978 com-
munist takeover and the 1979 Soviet invasion, six mil-
lion Afghans sought asylum outside their homeland,
finding refuge all over the world, though primarily in
Iran and Pakistan [39]. As of 2016, there were 1.5
million registered Afghan refugees in Pakistan and
951,000 in Iran [40]. The stresses of internal and exter-
nal displacement of refugees has been shown to facilitate
drug addiction and sex trade, putting them at risk for
blood-borne and sexually transmitted infections [41–43].
A study comparing awareness and high-risk practices
between Pakistani and Afghan drug users in Quetta,
Pakistan, found that the Afghan refugees were more
likely to practice injection drug use and needle sharing.
The Afghans were less likely to know about HIV/AIDS
or use a condom during sexual intercourse. Afghans
were also less likely than Pakistanis to be educated or
employed and more likely to be homeless [44]. It is not
surprising that the prevalence of HIV and other blood-
borne infections is high among Afghan refugees. In a
sample of 556 refugees, one study found significant
burden of HIV (6%), HBV (9%), and HCV (37%) [19].
In 2002, the United Nations High Commissioner for
Refugees, under an agreement with the Afghan, Pakistani,
and Iranian governments, began the largest repatriation
program in history, aiming to send back 5.7 million
Afghan refugees to their home country by 2012 [45]. By
2015, 5.8 million refugees had returned to Afghanistan
[46]. While the program has been well intentioned from
its outset, it has overlooked the implications of the high
burden of infectious diseases in the repatriating popula-
tion and the potential for resettling refugees to introduce
novel strains of pathogens into the native Afghan commu-
nities [47].
In a study of Canadian Muslims, it was found that
faith-based programs can be employed to combat the
stigma associated with mental illness and addiction [48].
Cambodian refugees constitute the biggest refugee popu-
lation in the USA, and a study conducted two decades
after they first arrived here in 1975 found high rates of
mental illness (depression and post-traumatic stress dis-
order (PTSD)) among the population. The study also
found high rates (exceeding 90% in some categories) of
exposure to trauma before migration, however, after
arrival in the USA, the rates of exposure to trauma
lessened [49]. A study assessed the prevalence of
mental illness in the war-torn countries of Bosnia and
Herzegovina, Croatia, Kosovo, Serbia, and Republic of
Macedonia, among people who had been exposed to
war between 5 and 15 years previously. In this popu-
lation, the overall prevalence of mental illness was
found to be 44.8%, with PTSD (10.6–35.5%) and
major depression (4.1–37.3%) being the most frequent
mental disorders [50]. Such studies highlight the need
to promote long-term health for refugees and war
affectees.
Opiate production in Pakistan
Since Pakistan gained its independence in 1947, its his-
tory has been interspersed with political upheaval and
wars. In 1979, the Zia-ul-Haq government implemented
the Hudood Ordinances, banning a set of what were
deemed to be non-Islamic practices, among them being
the production and use of intoxicating substances [51]
(Fig. 2b). Ironically, that same year, Pakistan produced
its record opium crop of 800 tons [52]. In the 1980s,
Pakistan experienced a sharp increase in the number of
heroin users: with virtually none reported in 1979 to
100,000 in 1983 [53]. This may have been a result of the
anti-Soviet Afghan war that led to the flourishing of
poppy fields at the Durand line that separates Pakistan
and Afghanistan (Fig. 1). In 1997, the Control of the
Narcotic Substances Act came about, and by the year
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2000, Pakistan was declared a poppy-free country, mean-
ing it had less than 1000 hectares under cultivation. Fol-
lowing the Taliban’s 2000 ban on opium cultivation in
Afghanistan, prices rose and poppy fields re-emerged in
Pakistan. In 2003, a record 6703 hectares were culti-
vated [54, 55]. In 2010, a 5-year Drug Control Master
Plan was approved by the Pakistani parliament. This
plan outlined strategies to curb drug manufacture and
smuggling and to prevent and treat addiction [56].
(Figs. 2b and 4).
Drug use and HIV in Pakistan
Although the overall HIV prevalence in Pakistan re-
mains relatively low, it is alarmingly high in at-risk com-
munities. In 2011, HIV prevalence among FSW, male
sex workers (MSW), Hijra (transvestites) sex workers
(HSW), MSM, and PWID was respectively 0.6, 1.6, 5.2,
7.2, and 27.2% [17, 57]. The earliest epidemic of HIV
among PWID communities was thought to have been
introduced by Pakistani migrant workers who were
deported from the Gulf countries after having contracted
HIV [58]. Evidence of a “founder effect” was shown in a
PWID community infected with HIV subtype A, likely
transmitted by a deportee from the Gulf [59, 60]. A sur-
vey conducted in the Pakistani city of Sargodha showed
emergence of a new injecting behavior called “scale,”
where an experienced street injector helps a novice,
injecting almost half of a heroin mixture into the nov-
ice’s blood while saving the blood-contaminated rest of
the mixture as payment or “scale” [61]. Figures from
2000 to 2011 show that there has been a steady rise in
the population of PWID and heroin users in Pakistan.
Not surprisingly, this rise closely aligns with an increase
in HIV prevalence in this group from 3% in 2002 to
27.2% in 2011 (Fig. 5) [17].
Compared to PWID, the prevalence of HIV in other
high-risk groups has stayed relatively low, albeit steadily
rising, over the years. Mapping exercises have shown
that there are 149,000 FSW in Pakistan. Data from 2011
show that 80% of FSW had heard of HIV/AIDS. Of
these, most (94%) knew that HIV could be transmitted
sexually, whereas only one third (33%) were aware that
contaminated needles could be a source of transmission
as well. A little more than 15% of the FSW reported that
they had had intercourse with PWID, and 7% admitted
to injecting drugs [17, 62]. HIV prevalence in the MSW
population in Pakistan has increased from 0.4% in 2005
to 1.6% in 2011. While a majority (95%) of MSWs knew
that HIV could be transmitted sexually, less than a half
(46%) were aware that the virus could also spread
through contaminated needles. In the same survey, 2%
MSWs had injected drugs and 10% had sex with PWID
[17, 62]. Hijra are a vulnerable, marginalized population;
they are shunned by society and have limited access to
healthcare services. According to 2014 estimates, ap-
proximately 50,000 HSW currently reside in Pakistan.
According to a survey, although most (91%) HSW had
good knowledge about HIV/AIDS, condom use with
paying (24%) and non-paying partners (18%) was ser-
iously lacking. Only 3% had injected drugs while 10%
had had sex with PWID [17, 62].
Khanani et al. have reported a rising HIV epidemic
in the MSM community in Pakistan. The study sug-
gests that MSM who inject drugs may be responsible
for bridging the epidemic between MSM and PWID
[63].The MSM community in Pakistan is heavily stig-
matized, since male-to-male sex is prohibited by reli-
gious edicts and social norms. MSM are therefore
known to practice bisexuality while legally married to
a female spouse. This hidden high-risk population
acts as a vehicle for the transmission of HIV from
the MSM population to the general population [58].
Fig. 4 Opium cultivation (hectares) in Pakistan from 1992 to 2011
[71, 109, 110]
Fig. 5 Heroin users, PWID, and the prevalence of HIV in PWID in
Pakistan. HIV prevalence is shown from 2002 to 2011. Number of
heroin users, PWID, and HIV prevalence is shown in, respectively,
blue, pink, and green [15–17, 53, 111]
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Opiates in Iran
With 1.8 million opiate users in 2013, Iran has one of
the highest opiate dependency rates in the world [64].
Social acceptance of opium smoking, in Iran, came
about in the sixteenth century when it was first culti-
vated here [65]. During the 1920s, the opium trade con-
stituted a quarter of Iran’s exports. In 1955, opium was
banned in Iran, which may have indirectly contributed
to the subsequent rise in opium production in
Afghanistan and Pakistan. In 1969, the Iran reversed its
policy and legalized opium cultivation [66], although
drug trafficking remained a crime punishable by death
(Fig. 2c) [67]. In June 1979, the Khomeini regime in Iran
announced an International ban on currently illicit
drugs, codifying it into law in January 1980. Drug use
continued to increase, however, because neighboring
Afghanistan produced large amounts of opium, which
was trafficked into Iran, and westward from there. In
September 1980, Iraq invaded Iran, giving rise to a con-
flict that lasted 8 years. As more and more resources
were channeled into fighting the war, use of illicit drugs
began to proliferate once again [68]. This war ended
with a UN ceasefire in August 1988 [69]. After Saddam
Hussein’s removal from Iraqi presidency in 2003, the
Iran–Iraq border became porous, opening a new route
for the trafficking of Afghan heroin [70].
According to a 1993 estimate, Iran had 3500 hectares
of poppy under cultivation [71] much less than the hec-
tarage noted in Pakistan (8185 ha.) [72] and Afghanistan
(58,000 ha.) [73]. Follow-up surveys in 1998 and 1999
found no poppy being cultivated in Iran [64], whereas
the 1999 figures for Pakistan and Afghanistan were re-
spectively 1481 [72] and 91,000 ha. [73]. The reason for
this rapid decline in poppy cultivation could be the com-
petition—neighboring Afghanistan provided opium at
much cheaper rates to the world market [71].
In a study of 1136 operating room patients, Alavi et al.
found that 126 patients had used illicit drugs, with opium
being the most frequently used drug (57%). The most
common routes of drug use were swallowing (49.5%) and
smoking (59%) [74]. In a national population size estima-
tion study of illicit drug users, it was found that opium
was the most common illicit drug used (1500 per 100,000
population), followed by shire (600), crystal methampheta-
mine (590), hashish (470), heroin/crack (350), metham-
phetamine/LSD/ecstasy (300), and injecting drugs (280).
All types of substance use were more common among
men than women, while people over 30 were more likely
to inject drugs [75]. Iran has invested a billion dollars in
border security to interrupt opium smuggling [76]. After
establishing the Drug Control Headquarters in 1988,
Iranian authorities intercepted increasing amounts of
smuggled opium: from 21 metric tons of opium in 1990
[77] to 580 metric tons in 2009 [78] (Fig. 6). While the
governments of Afghanistan and Pakistan have been con-
currently seizing smuggled opium as well, the efforts by
Iranian law enforcement authorities have been far more
aggressive (Fig. 6). At the same time, the Iranian govern-
ment was cracking down on illicit drug trade, a legal foun-
dation was being laid for the treatment of people
dependent on drugs without fear of prosecution or penalty
of treatment seekers or providers. Consequently, the
UNODC opened an office in Iran at the end of the 1990s
and the first methadone clinic was opened in 2002 [70].
Iran is currently one of 22 countries that provides harm
reduction services to prisoners [70]. However, a large
number of prisoners in Iran are incarcerated on drug-
related offences (between 1980 and 2000, as many as
1,700,000 were jailed on drug charges). In recognition of
this fact, in 2005, Iranian judge Esmail Shooshtari ordered
that drug users should be treated instead of punished [79,
80]. A systematic review of opioid use and treatment in
the Persian Gulf states found that with the exception of
Iran, harm reduction services were not available in that re-
gion due to the punitive Islamic laws that criminalize drug
use. In all countries besides Iran, there was a scarcity of
statistics on opioid use [81]. Harm reduction programs
have been implemented successfully in other Muslim-
majority countries such as Malaysia and have proved to be
sustainable and cost-effective, preventing nearly 12,000
new HIV infections [82].
HIV in Iran
There are three principal groups in Iran at high risk for
HIV infection: PWID, FSW, and prisoners. In 2014,
there were an estimated 170,000 to 230,000 PWID in
the country [83]. The IBBS 2008 and 2010 reported an
HIV prevalence of 15% among PWID [18]. In a qualita-
tive study of 154 PWID living in Tehran, nearly two
thirds were either unemployed or engaged in illegal jobs.
Fig. 6 Opium seizures in Iran (yellow) [7, 78, 112, 113], Afghanistan
(pink) [7, 16, 112], and Pakistan (blue) [7, 16] from 1996 to 2008
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Of these, 23 (15%) were women who reported engaging
in sex work to fund their drug habit [84]. In 2010, there
were an estimated 80,000 FSW in Iran. From the IBBS
2010, HIV prevalence among 872 FSW was estimated at
4.5%. Among these respondents, 74% had used drugs; of
these, 21% admitted to injecting drugs. In their most
recent sexual encounter, 57 and 36% FSWs reported
condom use, with paying and non-paying clients, re-
spectively [85]. According to IBBS 2009, HIV prevalence
in Iranian prisoners was 2%. One fifth (21%) knew about
HIV, and a quarter (25%) reported condom use in their
last intercourse, whereas 17% had history of injection
drug use and 13% had received tattoos in prison [86].
Another bio-behavioral survey conducted in 2012–2013
found the overall HIV prevalence among prisoners to be
1.4%. Among those who had been injecting drugs, it was
5% [83]. In a study of 252 prisoners in Iran, prevalence
of HIV, HCV, and HBV was found to be, respectively,
15, 65, and 5%; 14% were found co-infected with HIV
and HCV and 1% with HIV, HBV, and HCV [87]. There
are no representative studies to gauge the HIV preva-
lence in the MSM population in Iran [83]. According to
a 2011 report, 29% of unmarried, sexually active men in
Iran have had anal sex with other men [88].
Conclusion
The Golden Crescent continues to be plagued by an in-
transigent problem of opiate trade and use and a rising
incidence and prevalence of HIV and other blood-borne
infections. The governments in the three countries have
made several efforts to address the issue of drug use as
well as the rising HIV epidemics. Afghanistan, Iran, and
Pakistan have ratified the three international conven-
tions (1961, 1971, and 1988) that regulate the manufac-
ture, trade, and use of illicit drugs [89]. Social
acceptance of drug addiction as a disease and not a
crime has been promoted in Pakistan through programs
such as the organization Narcotics Anonymous that
works under the Mary Adelaide Leprosy Center [90].
Such support groups are effective because they provide a
resource for motivation and support for drug users [91].
In a similar vein, Iran has taken the step of making med-
ical treatment for drug addiction legal [70] and opening
clinics and support centers specifically for drug depen-
dents [92]. Iran envisions legalizing opium and
marijuana cultivation and seeks to abolish the death
penalty for drug trafficking [93, 94]. In Afghanistan gov-
ernment and NGO-funded, harm reduction programs
provide drug abstinence-based treatment. In 2002, there
were only two treatment centers in Kabul, but by 2011,
this figure rose to 14 [95]. The number of drug treat-
ment centers across all of Afghanistan also rose from 43
in 2009 to 108 in 2013, with the capacity to treat more
than 27,000 drug users [96]. The Organization for Harm
Reduction in Afghanistan (OHRA) has been functional
since 2011 and acts as an advocate for the vulnerable
populations by screening, preventing, and treating HIV/
AIDS [97].
Needle-exchange centers have been established in
major cities of Pakistan to tackle needle-sharing practice
among PWID. Needle-syringe exchange programs col-
lect used syringes from the injectors and provide them
with sterile ones. The workers at these centers also edu-
cate drug users about HIV and refer them to appropriate
treatment centers. Studies have shown that HIV preva-
lence decreases in areas where such programs operate
[98]. Such programs are the need of the hour and must
be promoted in all three countries of the Golden
Crescent.
Opium production may be curtailed in the Golden
Crescent countries through different approaches. Finan-
cial incentives may be offered to encourage the farmers
to cultivate alternative crops, such as saffron, pomegran-
ate, grapes, and almonds [99, 100], that may bring finan-
cial returns comparable to revenues generated from
poppy cultivation. Farmers can be convinced that such
crops will provide a more steady income compared to
opium, particularly as opium may be seized and
destroyed by the law enforcement agencies. Govern-
ments should assist farmers in doing so by providing
better irrigation, disseminating education about agricul-
ture, distributing seeds, and setting up agriculture mar-
kets [100]. It has been proposed that the Afghan
government should halt eradication of low-income
farmers’ crops and instead focus on the wealthy land-
owners as they have more to lose. In fact, there is evi-
dence that after eradication, wealthy landowners are less
likely to replant opium as losing an opium crop can be
costly and they would rather invest in licit, low-risk
crops. Efforts need to be made to interdict drug traf-
fickers. With international support, opium cultivation
can be legalized in Afghanistan, as there is an unmet
need in developing countries for opium-based medi-
cines. Following the model of Turkey, Afghanistan could
potentially step in to meet the licit opiate needs of the
developing countries; however, it is challenging to
legalize a crop such as opium as it requires political sta-
bility and expertise to prevent misuse [100]. Awareness
should be engendered among the farmers on how opium
can be harmful on a larger scale, facilitating the spread
of infections and prostitution [101]. A recent publication
from Pakistan shows how media can be effective in pre-
paring a nation to think about matters related to sex and
sexually transmitted diseases [102]. Another alternative
to opium is the oil mining industry that could help kick-
start the Afghan economy [103]. Public health experts,
religious leaders, politicians, and the media need to en-
gage in dialogue and be encouraged to collaborate in
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changing the mindset of poppy farmers, drug traders
and users, commercial sex workers, and the general pub-
lic about the menace of heroin use and of the growing
HIV epidemic in the Golden Crescent region.
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